User:Mr. Ibrahem/Methazolamide
Appearance
Clinical data | |
---|---|
Other names | N-(3-Methyl-5-sulfamoyl-3H-1,3,4-thiadiazol-2-ylidene) ethanamide |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601233 |
Routes of administration | By mouth |
Drug class | Carbonic anhydrase inhibitor[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | ~55% |
Onset of action | Within 4 hrs[1] |
Elimination half-life | ~14 hours |
Duration of action | Up to 18 hrs[1] |
Identifiers | |
| |
Chemical and physical data | |
Formula | C5H8N4O3S2 |
Molar mass | 236.26 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Methazolamide, sold under the brand name Neptazane among, is a medication used to treat increased intraocular pressure (IOP) including in glaucoma.[1] It is taken by mouth.[1] Effects begin within 4 hours and last for up to 18 hours.[1]
Common side effects include numbness, hearing problems, tiredness, nausea, diarrhea, and sleepiness.[1] Other side effects may include Stevens-Johnson syndrome.[1] It is an carbonic anhydrase inhibitor which decreases the production of aqueous humor.[1]
Methazolamide was approved for medical use in the United States in 1950s.[1][2] In the United States 60 tablets of 50 mg costs about 125 USD as of 2021.[3]
References
[edit]- ^ a b c d e f g h i j k l "Methazolamide Monograph for Professionals". Drugs.com. Archived from the original on 7 May 2021. Retrieved 17 November 2021.
- ^ Supuran, Claudiu T.; Nocentini, Alessio (17 July 2019). Carbonic Anhydrases: Biochemistry and Pharmacology of an Evergreen Pharmaceutical Target. Academic Press. p. 271. ISBN 978-0-12-816745-8. Archived from the original on 17 November 2021. Retrieved 17 November 2021.
- ^ "Methazolamide Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 5 November 2016. Retrieved 17 November 2021.